Latest Articles

Differential Diagnosis Of Late Onset Pompe Disease (LOPD) and Myotonic Dystrophy Type 1 Through Abdominal Ultrasonography

Slowing of brain atrophy with Teriflunomide

Daily Burden of CRSwNP

Why has our brain suddenly become of interest?

The reason for MS – beyond focal inflammation

The importance of deep grey matter in MS

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

MS Updates

MS Newsletter

Measuring brain atrophy. What can be done and where are we heading?